Cargando…
Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats
Cerebrolysin (CBL), a mixture of several active peptide fragments and neurotrophic factors including brain-derived neurotrophic factor (BDNF), is currently used in the management of cognitive alterations in patients with dementia. Since Cognitive decline as well as increased dementia are strongly as...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686810/ https://www.ncbi.nlm.nih.gov/pubmed/23840309 http://dx.doi.org/10.1371/journal.pone.0064847 |